Skip to main content
. 2020 Oct 12;26(1):e142–e152. doi: 10.1002/onco.13544

Table 1.

Participant characteristics stratified by whether they reported OOP costs or did not report OOP costs, by time point

Characteristic, n (%) Overall (n = 395) 1 week postsurgery 12 weeks postsurgery 1 year postsurgery
Missing OOP (n = 171) Reported OOP (n = 268) p value a Missing OOP (n = 152) Reported OOP (n = 257) p value a Missing OOP (n = 89) Reported OOP (n = 94) p value a
Socioeconomic status .97 .95 .01
Lower 136 (34.4) 59 (34.5) 92 (34.3) 51 (33.6) 87 (33.9) 40 (45.0) 25 (27.0)
Higher 259 (65.6) 112 (65.5) 176 (65.7) 101 (66.4) 170 (66.1) 49 (55.0) 69 (73.0)
Age .57 .90 .67
Less than 65 231 (58.5) 98 (57.3) 161 (60.1) 92 (60.5) 154 (59.9) 52 (58.0) 52 (55.0)
65 and older 164 (41.5) 73 (42.7) 107 (39.9) 60 (40.5) 103 (40.1) 37 (42.0) 42 (45.0)
Race .71 .94 .001
White, non‐Hispanic 254 (64.3) 111 (64.9) 175 (65.3) 102 (67.1) 172 (66.9) 53 (60.0) 75 (80.0)
Black, non‐Hispanic 55 (13.9) 21 (12.3) 38 (14.2) 20 (13.2) 33 (12.8) 8 (9.0) 10 (11.0)
Other 78 (19.7) 36 (21.1) 49 (18.3) 26 (17.1) 48 (18.7) 26 (29.0) 8 (9.0)
Missing 8 (2.0) 3 (1.8) 6 (2.2) 4 (2.6) 4 (1.6) 2 (2.0) 1 (1.0)
Surgery choice .83 .21 .40
Lumpectomy 313 (79.2) 121 (70.8) 213 (79.5) 104 (68.4) 209 (81.3) 72 (81.0) 82 (87.0)
Mastectomy 80 (20.3) 33 (19.3) 55 (20.5) 33 (21.7) 48 (18.7) 15 (17.0) 12 (13.0)
Missing 2 (0.5) 17 (9.9) 0 (0.0) 15 (9.9) 0 (0.0) (2.0) 0 (0.0)
Cancer stage .57 .10 .53
Stage I 270 (68.4) 109 (63.0) 188 (70.1) 95 (62.5) 183 (71.2) 62 (70.0) 73 (78.0)
Stage II 109 (27.6) 49 (28.7) 72 (26.9) 50 (32.9) 65 (25.3) 25 (28.0) 20 (21.0)
Stage III 10 (2.5) 5 (2.9) 5 (1.9) 1 (0.7) 6 (2.3) 1 (1.0) 1 (1.0)
Missing 6 (1.5) 8 (4.7) 3 (1.1) 6 (3.9) 3 (1.2) 1 (1.0) 0 (0.0)

Does not include participants who discontinued before specified time point or participants where this follow‐up was due after data collection ended.

a

Chi‐square tests were used to test for statistical differences between groups.

Abbreviation: OOP, out‐of‐pocket.